Discover
FATE
Fate Therapeutics, Inc.
3.02
2 x 2.22
2 x 3.40
bid
ask
+
0.32
11.85%
2 @ 05:55 AM
2.97 -0.05 (1.59%)
| Ytd | 208.16% | |
| 1y | 164.91% |
2.64
day range
3.11
0.91
52 week range
3.11
| Open | 2.65 | Prev Close | 2.70 | Low | 2.64 | High | 3.11 | Mkt Cap | 352.01M |
| Vol | 5.86M | Avg Vol | 3.75M | EPS | -1.09 | P/E | N/A | Forward P/E | -0.99 |
| Beta | 1.88 | Short Ratio | 3.10 | Inst. Own | 102.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 2.02 | 200-d Avg | 1.40 | 1yr Est | 6.31 |
| Income Statement | |||
| Total Revenue | 1.30M | ||
| Revenues (USD) | 1.30M | ||
| Gross Profit | 1.30M | ||
| Operating Expenses | 34.30M | ||
| Research and Development Expense | 24.70M | ||
| Selling, General and Administrative Expense | 9.60M | ||
| Operating Income | -33.00M | ||
| Net Income | -31.21M | ||
| Net Income Common Stock | -31.21M | ||
| Net Income Common Stock (USD) | -31.21M | ||
| Consolidated Income | -31.21M | ||
| Earnings per Basic Share | -0.26 | ||
| Earnings per Basic Share (USD) | -0.26 | ||
| Earnings per Diluted Share | -0.26 | ||
| Earning Before Interest & Taxes (EBIT) | -31.21M | ||
| Earning Before Interest & Taxes (USD) | -31.21M | ||
| Weighted Average Shares | 120.03M | ||
| Weighted Average Shares Diluted | 120.03M | ||
| Balance Sheet | |||
| Cash and Equivalents | 49.62M | ||
| Cash and Equivalents (USD) | 49.62M | ||
| Investments | 135.25M | ||
| Investments Current | 135.25M | ||
| Trade and Non-Trade Receivables | 704.00K | ||
| Current Assets | 179.53M | ||
| Property, Plant & Equipment Net | 95.34M | ||
| Total Assets | 284.92M | ||
| Debt Current | 4.74M | ||
| Total Debt | 76.79M | ||
| Current Liabilities | 30.69M | ||
| Debt Non-Current | 72.05M | ||
| Total Liabilities | 105.21M | ||
| Accumulated Retained Earnings (Deficit) | -1.57B | ||
| Accumulated Other Comprehensive Income | -77.00K | ||
| Shareholders Equity | 179.71M | ||
| Shareholders Equity (USD) | 179.71M | ||
| Assets Non-Current | 105.39M | ||
| Total Debt (USD) | 76.79M | ||
| Deferred Revenue | 582.00K | ||
| Liabilities Non-Current | 74.52M | ||
| Trade and Non-Trade Payables | 3.28M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.92M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.23M | ||
| Capital Expenditure | -239.00K | ||
| Net Cash Flow from Investing | 23.59M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 23.83M | ||
| Net Cash Flow from Operations | -30.82M | ||
| Share Based Compensation | 3.93M | ||